|Articles|January 15, 2003
- BioPharm International-01-01-2003
- Volume 16
- Issue 1
Survival Strategies: Board Compensation Changing with the Times
Author(s)Jack Dolmat
by Jack Dolmat, Clark/Bardes Consulting Compensation for board members varies widely with company size, but as more is expected, compensation practices are changing too.
Advertisement
Articles in this issue
about 23 years ago
Biotech World: Canada's Supreme Court says "No" to Harvard Mouseabout 23 years ago
Guest Editorial: At the Governance Crossroadabout 23 years ago
Reducing Costs by Facility Designabout 23 years ago
Guidelines for Optimization and Scale-Up in Preparative ChromatographyNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
FDA October 2025 Draft Guidance Sparks Industry Biosimilars Buzz
2
How Biopharma Navigates the 2026 Economic Shift
3
Adenovirus Vectors, Cyclodextrins and the Patient Experience: A Deep Dive
4
EC’s High-Dose Aflibercept Approval Highlights Durable Anti-VEGF Retinal Therapy
5
